Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
about
Colorectal Cancer Biomarkers: Where Are We Now?Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.Biomarkers for colorectal cancerVariant Ciz1 is a circulating biomarker for early-stage lung cancerPotential of soluble CD26 as a serum marker for colorectal cancer detection.Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.Proteomic and metabolic prediction of response to therapy in gastric cancer.Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer.Proteomic methodologies and their application in colorectal cancer research.Integrative oncoproteomics strategies for anticancer drug discovery.Serum tests for colorectal cancer screening.Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancers.Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.Retraction: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
P2860
Q27003134-72E18992-9C19-486F-AD5A-F962B9643279Q33618421-C6234559-C5F0-4FB9-902F-9D41D8ACB9A6Q33966180-C03555A5-DBA1-45BA-86FE-3BB826CBB27AQ34205596-85CA6648-D048-4168-B05D-1FDD96620CB5Q34306595-9875F7EC-A8ED-40A3-BBB4-6F146EA6F14EQ35113393-CD63C608-5EC1-4C3C-B229-C55795968887Q35125657-8CC9ABE2-5EF3-467D-B51A-104103CBD2B7Q35336183-652856A9-948A-444D-8379-FBE5AFD9A324Q36267118-124A2046-75D6-4766-AAE2-7441C3D78865Q37643738-41F0DEF2-1DDE-4D0D-8016-9CA63ABAD4E5Q37763937-4FD5D3D4-BB78-4561-B285-F4C8EE36E971Q37902210-08227BF5-9457-4F69-976D-7575FA397CDCQ38089897-A72971FF-9DE6-4814-8827-2A31778F582BQ38316610-4D5A75D4-FC00-44E1-9822-03D010AF8BA9Q43141762-290010F9-BC2A-486E-92B9-E9E5687BD520Q50952649-A7899248-4426-4025-BF80-CFD0432FEFABQ51765488-433A72DD-72DA-4869-888B-3FC112B173C2
P2860
Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@ast
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@en
type
label
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@ast
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@en
prefLabel
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@ast
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@en
P2093
P2860
P1476
Evaluation of colon cancer-spe ...... marker for colorectal cancer.
@en
P2093
Ahmed Magheli
Daniel W Chan
Eddy S Leman
Lori J Sokoll
Robert E Schoen
Robert H Getzenberg
P2860
P304
P356
10.1158/1078-0432.CCR-07-4110
P407
P577
2008-03-01T00:00:00Z